2006 Finance Operations Pharmaceuticals 
Harvard Business Review
OCTOBER 26, 2011
Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive.
Harvard Business Review
JUNE 20, 2017
Multinational companies operating in Mexico are facing a great deal of uncertainty. Firms in innovation-driven industries, such as pharmaceuticals and medical devices, have long supported greater standardization across borders, with stronger intellectual property protections and enforcement of regulatory standards.
Expert insights. Personalized for you.
10 
Let's personalize your content